PF-DcpSi
CAS No. 2092917-19-4
PF-DcpSi ( —— )
Catalog No. M13280 CAS No. 2092917-19-4
A potent inhibitor of the mRNA decapping scavenger enzyme (DcpS) with IC50 of 0.11 nM; shows no significant activity for DHFR (IC50>30 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-DcpSi
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent inhibitor of the mRNA decapping scavenger enzyme (DcpS) with IC50 of 0.11 nM; shows no significant activity for DHFR (IC50>30 uM).
-
DescriptionA potent inhibitor of the mRNA decapping scavenger enzyme (DcpS) with IC50 of 0.11 nM; shows no significant activity for DHFR (IC50>30 uM); has in vivo mouse CNS PK profile, shows activity in SMA mouse model by prolonging survival and improving function thereby ruling out lysosomotropism.Spinal Muscular Atrophy (SMA)Preclinical
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research AreaNeurological Disease
-
IndicationSpinal Muscular Atrophy(SMA)
Chemical Information
-
CAS Number2092917-19-4
-
Formula Weight309.30
-
Molecular FormulaC16H12FN5O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1=CC(=C2C(=C1)N=C(N=C2N)N)COC3=CC(=CC(=C3)C#N)F
-
Chemical Name3-((2,4-diaminoquinazolin-5-yl)methoxy)-5-fluorobenzonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. J Med Chem. 2017 Apr 13;60(7):3094-3108.
molnova catalog
related products
-
Anle138b
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease.
-
Phenetole
Phenetole is used as an analyte to determine the properties of porous graphite carbon (PGC) particles.
-
5-Hydroxymethyl-2-fu...
5-Hydroxymethyl-2-furancarboxylic acid (Sumiki's acid) is a naturally occurring human metabolite. Sumiki's acid was first identified in the urine of a leukemia patient who was excreting an abnormal amount of its glycine derivative. Sumiki's acid has been found to be a byproduct of the fungus Aspergillus and probably other species of fungi and yeast as well.